Pharmacy Report Archives - Page 40 of 154 - Becker's Hospital Review

NY system enhances med management | Sanofi aims to alter 340B | Fla. plan to import drugs from Canada stalls | Clonazepam recalled over label error | Who can make GLP-1s? 5 notes

November 25, 2024 BHR Newsletter 1. NYC Health + Hospitals to upgrade medication management technology Full story 2. Florida drug importation plan stalls nearly a year after approval Full story 3. Drugmakers, pharmacists battle over who gets obesity drugs: 5 things…

ASHP taps CIO | Bomb cyclone pauses pharmacy services in Wash. | 10 systems seeking pharmacy leaders | NY's plan to curb PBMs | 6 in 10 patients worry over pharmacy deserts

November 21, 2024 BHR Newsletter 1. New York cracks down on PBM drug prices Full story 2. Rising prescription costs, pharmacy closures shape consumer attitudes: Survey Full story 3. ASHP taps chief information officer Full story 4. Rare disease patients…

Systems brace for possible 340B cuts | Hospital pharmacies enter new markets | PBMs sue FTC | 1st brain-injected gene therapy approved | Wash. hospital OKs pharmacy review in settlement

November 20, 2024 BHR Newsletter 1. Health systems brace for possible 340B cuts Full story 2. 1st gene therapy delivered directly into brain approved Full story 3. PBMs sue to stop FTC's case over insulin prices Full story 4. Rare…

Texas system averts 9K vaccine errors | The future of CDC, HHS under Trump | Lilly drug candidate cuts cardio risk by 86% | Generic GLP-1 to enter market in 2025 | Hospitals overhaul C-suites

November 19, 2024 BHR Newsletter 1. Eli Lilly drug cuts genetic form of cholesterol by 86%: Study Full story 2. Layoffs, pay cuts reshape hospital C-suites Full story 3. After averting 9,000 vaccine errors, ISMP awards Texas system Full story…

Hospital Rx safety advances: Leapfrog | 340B rebate challenges, explained | AI in hospital pharmacy: 4 execs | New drug ad rules take effect: 4 notes | 3 IV fluid shortage updates

November 18, 2024 BHR Newsletter 1. Drugmakers' 340B rebate fight, explained Full story 2. Pharmacy leaders explore AI's potential Full story 3. What's driving hospitals' medication safety advances? Full story 4. Ardent Health and MemorialCare are simplifying purchased services —…

The financial cost of drug shortages: Case study | FDA inspectors in short supply | 10 systems seeking pharmacy leaders | FDA rejects full approval of liver disease drug | Mounjaro helps 99% of prediabetes patients: Study

November 14, 2024 BHR Newsletter 1. FDA struggles to retain inspectors: GAO Full story 2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story 3. The financial burden of drug shortages: 7 study takeaways Full story…

J&J renews push for 340B rebates | What retail pharmacy closures mean for hospitals | Kaiser posts $608M Q3 loss, cites high pharmacy costs | Inova cuts daily IV fluid use in half | Pros, cons to ambulatory pharmacies

November 13, 2024 BHR Newsletter 1. What retail pharmacy closures spell for healthcare Full story 2. J&J sues government over 340B rebate plan Full story 3. Hospital operator plans to sell 10 of 16 hospitals Full story 4. Pharmacy-HR collaboration…

9 new drug shortages | 2024's biggest wins, per 5 hospital pharmacy execs | Clinical hold ends for combo flu, COVID vaccine trial | Mich. pharmacist convicted in $15M case | Wis. system CEO to step down

November 12, 2024 BHR Newsletter 1. Pharmacy leaders highlight 2024's top achievements Full story 2. 9 drugs now in shortage Full story 3. FDA lifts clinical hold on combined COVID-19-influenza vaccine trials Full story 4. Large academic medical center boosts…

U of Calif. pharmacy workers to strike | Pharmacy directors, techs in high demand | Cleveland Clinic's cancer vaccine shows promise | 3 Ozempic updates | ASHP taps pharmacy leadership VP

November 11, 2024 BHR Newsletter 1. Breast cancer vaccine produces immune response: Cleveland Clinic Full story 2. Half of US hospitals have enough IV fluids for 2 weeks Full story 3. Pharmacy directors, techs in high demand Full story 4.…

FDA weighs pulling common decongestant | New warning added to GLP-1 labels | Calif. might restrict 340B spending | 10 systems seeking pharmacy leaders | Pharmacists sue La. over abortion pill classification

November 7, 2024 BHR Newsletter 1. FDA proposes pulling common decongestant from shelves Full story 2. Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO Full story 3. 340B spending restrictions on track for passage in California Full story 4.…